LightDeck Diagnostics Receives $2M for Development of Respiratory Illness Inflammation Test
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read More
Search Results for: liver disease
Siemens Healthineers Launch Enhanced Liver Fibrosis Test in US
The ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read More
Pathogenomix Bacteria Diagnosis Assay Granted FDA Breakthrough Device Designation
The FDA has granted Pathogenomix with a Breakthrough Device Designation for its Patho-Seq assay due to its methodologies of pathogenic bacteria diagnosis.
Read More
Akoya Biosciences Launches Single-Cell Spatial Biology System
Akoya Biosciences has announced the commercial availability of the PhenoCycler-Fusion system for high-speed imaging of whole slides.
Read More
Brain Cell Damage Markers Higher in COVID Patients than Alzheimer’s Patients
The new study found higher levels of seven markers of brain damage in COVID-19 patients with neurological symptoms than those without them.
Read More